We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$327B
AUM Growth
+$39.5B
Cap. Flow
+$29.4B
Cap. Flow %
8.99%
Top 10 Hldgs %
41.94%
Holding
5,455
New
406
Increased
1,053
Reduced
2,806
Closed
646

Sector Composition

Rank Sector Weight
1 Technology 22.33%
2 Consumer Discretionary 7.25%
3 Financials 7.18%
4 Communication Services 6.16%
5 Healthcare 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPRE icon
2351
Green Plains
GPRE
$1.08B
$1.32M ﹤0.01%
83,287
+25,255
+44% +$486K
AMPX icon
2352
CALL
Amprius Technologies
AMPX
$1.63B
$1.32M ﹤0.01%
1,040,000
FCF icon
2353
First Commonwealth Financial
FCF
$2.19B
$1.32M ﹤0.01%
95,502
-72,584
-43% -$971K
VNO icon
2354
CALL
Vornado Realty Trust
VNO
$7.35B
$1.31M ﹤0.01%
50,000
-46,000
-48% -$1.18M
AKRO
2355
DELISTED
Akero Therapeutics
AKRO
$1.31M ﹤0.01%
56,016
-14,665
-21% -$314K
GH icon
2356
CALL
Guardant Health
GH
$21.3B
$1.31M ﹤0.01%
+45,500
New +$1.06M
AXSM icon
2357
Axsome Therapeutics
AXSM
$10.9B
$1.31M ﹤0.01%
16,276
-203,822
-93% -$15.1M
SNDR icon
2358
Schneider National
SNDR
$6.26B
$1.31M ﹤0.01%
54,141
-24,606
-31% -$544K
DCO icon
2359
Ducommun
DCO
$3.09B
$1.31M ﹤0.01%
22,509
-7,681
-25% -$429K
VIG icon
2360
Vanguard Dividend Appreciation ETF
VIG
$114B
$1.31M ﹤0.01%
7,150
+100
+1% +$18K
ALKT icon
2361
Alkami Technology
ALKT
$2.04B
$1.3M ﹤0.01%
45,811
-7,123
-13% -$184K
RGR icon
2362
CALL
Sturm, Ruger & Co
RGR
$608M
$1.3M ﹤0.01%
+31,300
New +$1.39M
AIR icon
2363
AAR Corp
AIR
$6.01B
$1.3M ﹤0.01%
17,925
-19,142
-52% -$1.3M
NVTS icon
2364
Navitas Semiconductor
NVTS
$3.29B
$1.3M ﹤0.01%
331,534
-270,173
-45% -$1.14M
U icon
2365
CALL
Unity
U
$17.6B
$1.3M ﹤0.01%
80,000
-379,800
-83% -$8.13M
BTU icon
2366
Peabody Energy
BTU
$2.9B
$1.3M ﹤0.01%
58,771
-44,050
-43% -$1.02M
HOPE icon
2367
Hope Bancorp
HOPE
$1.79B
$1.3M ﹤0.01%
120,760
-97,306
-45% -$1.02M
RC
2368
Ready Capital
RC
$276M
$1.3M ﹤0.01%
158,519
-103,982
-40% -$886K
HWKN icon
2369
Hawkins
HWKN
$2.76B
$1.29M ﹤0.01%
14,183
-10,089
-42% -$827K
MNDY icon
2370
monday.com
MNDY
$3.67B
$1.29M ﹤0.01%
5,349
-15,014
-74% -$3.17M
NNI icon
2371
Nelnet
NNI
$4.8B
$1.29M ﹤0.01%
12,751
-7,149
-36% -$711K
IRWD icon
2372
Ironwood Pharmaceuticals
IRWD
$700M
$1.28M ﹤0.01%
197,016
-93,229
-32% -$659K
CLFD icon
2373
Clearfield
CLFD
$356M
$1.28M ﹤0.01%
33,301
-7,129
-18% -$248K
RIG icon
2374
CALL
Transocean
RIG
$5.82B
$1.28M ﹤0.01%
+240,000
New +$1.39M
CVLG icon
2375
Covenant Logistics
CVLG
$887M
$1.28M ﹤0.01%
52,048
-1,490
-3% -$34.6K

Similar funds

Barclays's Q2 2024 Portfolio in Review

As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.

  • Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
  • Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
  • Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
  • Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
  • Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
  • Barclays opened 406 new positions and closed 646 in Q2 2024.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $327B.

Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.